Andrew J. Schwab's Net Worth

$2.49 Billion

Who is Andrew J. Schwab?

Andrew J. Schwab has an estimated net worth of $2.49 Billion. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Skye Bioscience, Inc., CinCor Pharma, Inc., Flexion Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS, INC., 5:01 Acquisition Corp., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., and EPIRUS Biopharmaceuticals, Inc..

SEC CIK

Andrew J. Schwab's CIK is 0001598549

Past Insider Trading and Trends

2019 was Andrew J. Schwab's most active year for acquiring shares with 28 total transactions. Andrew J. Schwab's most active month to acquire stocks was the month of January. 2022 was Andrew J. Schwab's most active year for disposing of shares, totalling 56 transactions. Andrew J. Schwab's most active month to dispose stocks was the month of October. 2022 saw Andrew J. Schwab paying a total of $25,520,000.00 for 4,937,646 shares, this is the most they've acquired in one year. In 2019 Andrew J. Schwab cashed out on 13,292,745 shares for a total of $54,804,484.83, their largest year based on trade value.